– CHINA, Shanghai – Everest Medicines (HKEX: 1952), a biopharmaceutical company, today announced the appointment of Rogers Luo to its Board of Directors as Executive Director and CEO, effective immediately.…
– USA, NC – Brii Biosciences Limited (HKG: 2137), a multi-national company developing innovative therapies today announced the appointment of Dr.…
– CHINA, Shanghai – Clover Biopharmaceuticals, Ltd. (HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced the appointment of Dr.…
– USA, MA / CHINA, Beijing – CANbridge Pharmaceuticals, Inc. (HKG: 1228), a China-based global biopharmaceutical company committed to the research, development, and commercialization of transformative rare disease and rare oncology therapies, today announced the appointment of Dr.…
– USA, NY – Everest Medicines (HKG: 1952), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, today announced the appointment of Lan Kang to its Board of Directors as a non-executive director.…
